These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12646940)

  • 21. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
    Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
    Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
    Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
    Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia.
    Rudduck-Sivaswaren C; Tien SL; Lim P; Lim E; Lie DK; Tan PH; Lee AS
    Clin Genet; 2005 Nov; 68(5):461-5. PubMed ID: 16207215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biology of the Philadelphia positive leukaemias.
    Morgan GJ; Wiedemann LM
    Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
    Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
    Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
    Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
    Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isodicentric Philadelphia chromosome in acute lymphoblastic leukemia with der(7;12)(q10;q10).
    Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
    Leuk Res; 2007 May; 31(5):713-8. PubMed ID: 16979235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA; Hawkins A; Murphy KM; Griffin CA
    Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
    Kunieda Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of "biphenotypic" acute leukemia cell lines with a variant Ph translocation t(9;22;10) (q34;q11;q22).
    Ariyasu T; Matsuo Y; Harashima A; Nakamura S; Takaba S; Tsubota T; Orita K
    Hum Cell; 1998 Mar; 11(1):43-50. PubMed ID: 9710720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia.
    Inokuchi K; Shinohara T; Futaki M; Hanawa H; Tanosaki S; Yamaguchi H; Nomura T; Dan K
    Genes Chromosomes Cancer; 1998 Nov; 23(3):227-38. PubMed ID: 9790503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients.
    Storlazzi CT; Specchia G; Anelli L; Albano F; Pastore D; Zagaria A; Rocchi M; Liso V
    Genes Chromosomes Cancer; 2002 Nov; 35(3):271-6. PubMed ID: 12353269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.